OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Borja Guerra, Carlota Recio, Haidée Aranda-Tavío, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 98
Borja Guerra, Carlota Recio, Haidée Aranda-Tavío, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 151-151
Open Access | Times Cited: 77
Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 151-151
Open Access | Times Cited: 77
The potential use of simvastatin for cancer treatment: A review
Jaqueline Aparecida Duarte, André Luís Branco de Barros, Elaine Amaral Leite
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111858-111858
Open Access | Times Cited: 83
Jaqueline Aparecida Duarte, André Luís Branco de Barros, Elaine Amaral Leite
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111858-111858
Open Access | Times Cited: 83
Ferroptosis: The Entanglement between Traditional Drugs and Nanodrugs in Tumor Therapy
Kexuan Liu, Lei Huang, Shuangyan Qi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 12
Closed Access | Times Cited: 37
Kexuan Liu, Lei Huang, Shuangyan Qi, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 12
Closed Access | Times Cited: 37
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection
Alexis Yero, Ralph‐Sydney Mboumba Bouassa, Petronela Ancuța, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 69, pp. 1-13
Closed Access | Times Cited: 27
Alexis Yero, Ralph‐Sydney Mboumba Bouassa, Petronela Ancuța, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 69, pp. 1-13
Closed Access | Times Cited: 27
Gamma delta T cells in acute myeloid leukemia: biology and emerging therapeutic strategies
Adishwar Rao, Akriti Agrawal, Gautam Borthakur, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e007981-e007981
Open Access | Times Cited: 8
Adishwar Rao, Akriti Agrawal, Gautam Borthakur, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e007981-e007981
Open Access | Times Cited: 8
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Ying Qian, Ruiyun Fan, Yili Shen, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1112-1123
Closed Access | Times Cited: 8
Ying Qian, Ruiyun Fan, Yili Shen, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1112-1123
Closed Access | Times Cited: 8
Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
Derek Lee, Carl J. Rosenthal, Natalie E. Penn, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 3005-3005
Open Access | Times Cited: 31
Derek Lee, Carl J. Rosenthal, Natalie E. Penn, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 3005-3005
Open Access | Times Cited: 31
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
James A. McCubrey, Li V. Yang, Stephen L. Abrams, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2155-2155
Open Access | Times Cited: 30
Ferroptosis is a new therapeutic target for spinal cord injury
Xinyue Bai, Xiaolong Liu, Zhi-Zhong Deng, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 20
Xinyue Bai, Xiaolong Liu, Zhi-Zhong Deng, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 20
Acetyl-CoA metabolism as a therapeutic target for cancer
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 20
Guo Chen, Banghe Bao, Cheng Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115741-115741
Open Access | Times Cited: 20
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 18
Anti-Cancer and Anti-Oxidant Bioactive Metabolites from Aspergillus fumigatus WA7S6 Isolated from Marine Sources: In Vitro and In Silico Studies
Mervat G. Hassan, Waleed A. Elmezain, Dina M. Baraka, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 127-127
Open Access | Times Cited: 6
Mervat G. Hassan, Waleed A. Elmezain, Dina M. Baraka, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 127-127
Open Access | Times Cited: 6
Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression
Giorgia Centonze, Dora Natalini, Alessio Piccolantonio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Giorgia Centonze, Dora Natalini, Alessio Piccolantonio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer
Yi Xiao, Qin Liu, Nanyin Peng, et al.
Cell Transplantation (2022) Vol. 31
Open Access | Times Cited: 24
Yi Xiao, Qin Liu, Nanyin Peng, et al.
Cell Transplantation (2022) Vol. 31
Open Access | Times Cited: 24
Fatty acid synthase: a druggable driver of breast cancer brain metastasis
Javier A. Menéndez, Ruth Lupu
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 427-444
Closed Access | Times Cited: 24
Javier A. Menéndez, Ruth Lupu
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 5, pp. 427-444
Closed Access | Times Cited: 24
USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
Carina R. Maier, Oliver Hartmann, Cristian Prieto‐Garcia, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1710-1725
Open Access | Times Cited: 15
Carina R. Maier, Oliver Hartmann, Cristian Prieto‐Garcia, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1710-1725
Open Access | Times Cited: 15
Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography–Mass Spectrometry
Eray Schulz, Mark Woollam, Paul Grocki, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4533-4533
Open Access | Times Cited: 14
Eray Schulz, Mark Woollam, Paul Grocki, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4533-4533
Open Access | Times Cited: 14
Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
Daniel Tuyet Kristensen, Andreas Kisbye Øvlisen, Lasse Hjort Jakobsen, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3450-3457
Open Access | Times Cited: 13
Daniel Tuyet Kristensen, Andreas Kisbye Øvlisen, Lasse Hjort Jakobsen, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3450-3457
Open Access | Times Cited: 13
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs
Emanuela Chiarella, Clelia Nisticò, Anna Di Vito, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 21
Emanuela Chiarella, Clelia Nisticò, Anna Di Vito, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 21
Ferroptosis: a potential therapeutic target for Alzheimer’s disease
Lan Yang, Jianfei Nao
Reviews in the Neurosciences (2022) Vol. 34, Iss. 5, pp. 573-598
Closed Access | Times Cited: 19
Lan Yang, Jianfei Nao
Reviews in the Neurosciences (2022) Vol. 34, Iss. 5, pp. 573-598
Closed Access | Times Cited: 19
Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma
Gaurav Kumar Pandey, Nick Landman, Hannah K. Neikes, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100915-100915
Open Access | Times Cited: 12
Gaurav Kumar Pandey, Nick Landman, Hannah K. Neikes, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100915-100915
Open Access | Times Cited: 12
Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer
Gang Wang, Junjie Wang, Zhimin Zhu, et al.
Science Progress (2023) Vol. 106, Iss. 1
Open Access | Times Cited: 12
Gang Wang, Junjie Wang, Zhimin Zhu, et al.
Science Progress (2023) Vol. 106, Iss. 1
Open Access | Times Cited: 12
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
Minting Wen, Yingjing Li, Xiaonan Qin, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1882-1882
Open Access | Times Cited: 11
Minting Wen, Yingjing Li, Xiaonan Qin, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1882-1882
Open Access | Times Cited: 11
Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 597, pp. 217046-217046
Closed Access | Times Cited: 4
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 597, pp. 217046-217046
Closed Access | Times Cited: 4
Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers
Anna Røssberg Lauridsen, Aikaterini Skorda, Nuggi Ingholt Winther, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Anna Røssberg Lauridsen, Aikaterini Skorda, Nuggi Ingholt Winther, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
